159 related articles for article (PubMed ID: 12163380)
21. Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei.
Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763192
[TBL] [Abstract][Full Text] [Related]
22. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
23. Mucin as a therapeutic target in pseudomyxoma peritonei.
Choudry HA; O'Malley ME; Guo ZS; Zeh HJ; Bartlett DL
J Surg Oncol; 2012 Dec; 106(7):911-7. PubMed ID: 22585683
[TBL] [Abstract][Full Text] [Related]
24. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.
Yang K; Popova NV; Yang WC; Lozonschi I; Tadesse S; Kent S; Bancroft L; Matise I; Cormier RT; Scherer SJ; Edelmann W; Lipkin M; Augenlicht L; Velcich A
Cancer Res; 2008 Sep; 68(18):7313-22. PubMed ID: 18794118
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1.
Hokari R; Lee H; Crawley SC; Yang SC; Gum JR; Miura S; Kim YS
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G949-59. PubMed ID: 16227528
[TBL] [Abstract][Full Text] [Related]
26. Pseudomyxoma Peritonei.
Bartoška P; Antoš F; Vítek P; Marx J; Kopic J; Holečková P
Klin Onkol; 2019; 32(5):329-332. PubMed ID: 31610663
[TBL] [Abstract][Full Text] [Related]
27. Scalloping of the liver: Pseudomyxoma peritonei.
Xiang H; Han J; Ridley WE; Ridley LJ
J Med Imaging Radiat Oncol; 2018 Oct; 62 Suppl 1():103. PubMed ID: 30309123
[No Abstract] [Full Text] [Related]
28. Progress in Biological Research and Treatment of Pseudomyxoma Peritonei.
Li X; Liu G; Wu W
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611084
[TBL] [Abstract][Full Text] [Related]
29. The value of ultrasound combined with CT in identifying early low-grade appendiceal mucinous neoplasm and appendicitis.
Bai D; Zhou N; Dou R; Wang J; Zhang P; Wang H; Wang Z; Liang L
Front Oncol; 2023; 13():1191785. PubMed ID: 37849798
[TBL] [Abstract][Full Text] [Related]
30. Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei.
Villarejo-Campos P; García-Arranz M; Qian S; Jiménez de Los Galanes S; Domínguez-Prieto V; Vélez-Pinto JF; Guijo Castellano I; Jiménez-Fuertes M; Guadalajara H; García-Olmo D
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373701
[TBL] [Abstract][Full Text] [Related]
31. Advances in the management of peritoneal malignancies.
Kepenekian V; Bhatt A; Péron J; Alyami M; Benzerdjeb N; Bakrin N; Falandry C; Passot G; Rousset P; Glehen O
Nat Rev Clin Oncol; 2022 Nov; 19(11):698-718. PubMed ID: 36071285
[TBL] [Abstract][Full Text] [Related]
32. The Role of Microorganisms in Appendiceal Pseudomyxoma Peritonei: A Review.
Khamzina Y; King MC; Nieroda C; Merrell DS; Sardi A; Gushchin V
Curr Oncol; 2022 May; 29(5):3576-3584. PubMed ID: 35621679
[TBL] [Abstract][Full Text] [Related]
33. A case of Pseudomyxoma Peritonei of an unexpected origin.
Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC
Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348
[TBL] [Abstract][Full Text] [Related]
34. The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy.
Gangi A; Shah R
Ann Surg Oncol; 2022 Mar; 29(3):2056-2068. PubMed ID: 34853944
[TBL] [Abstract][Full Text] [Related]
35. The Biological Synthesis and the Function of Mucin 2 in Pseudomyxoma Peritonei.
Lin YL; Li Y
Cancer Manag Res; 2021; 13():7909-7917. PubMed ID: 34703312
[TBL] [Abstract][Full Text] [Related]
36. Pseudomyxoma peritonei originating from intestinal duplication: A case report and review of the literature.
Han XD; Zhou N; Lu YY; Xu HB; Guo J; Liang L
World J Clin Cases; 2021 Sep; 9(25):7459-7467. PubMed ID: 34616812
[TBL] [Abstract][Full Text] [Related]
37. Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.
Dilly AK; Honick BD; Frederick R; Elapavaluru A; Velankar S; Makala H; Hitchens TK; Foley LM; Guo J; Beumer JH; Rigatti LH; Lee YJ; Bartlett DL; Choudry HA
Transl Res; 2021 Mar; 229():100-114. PubMed ID: 33164812
[TBL] [Abstract][Full Text] [Related]
38. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
Lin YL; Ma R; Li Y
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
[TBL] [Abstract][Full Text] [Related]
39. The Diverse Roles of the Mucin Gene Cluster Located on Chromosome 11p15.5 in Colorectal Cancer.
Gan GL; Liu J; Chen WJ; Ye QQ; Xu Y; Wu HT; Li W
Front Cell Dev Biol; 2020; 8():514. PubMed ID: 32695780
[TBL] [Abstract][Full Text] [Related]
40.
Lawson PA; Patel NB; Mohammed A; Moore ERB; Lo AS; Sardi A; Davis JM; Doyle DA; Hui Y; Testerman T
Int J Syst Evol Microbiol; 2020 Jun; 70(6):3639-3646. PubMed ID: 32501783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
